The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.082
Bid: 0.08
Ask: 0.084
Change: 0.004 (5.13%)
Spread: 0.004 (5.00%)
Open: 0.0775
High: 0.088
Low: 0.0775
Prev. Close: 0.078
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Spire Health Selects CAP-XX Supercapacitors

7 Sep 2021 07:00

RNS Number : 8639K
CAP-XX Limited
07 September 2021
 

REACH

 

7 September 2021

 

CAP-XX Limited

 

("CAP-XX")

 

CAP-XX Supercaps Power Spire Health's Remote Respiratory Monitoring for Patients with Chronic Respiratory Diseases

 

Supercapacitors handle peak power role to keep Spire Health Tag's battery small and form factor thin

 

Sydney, Australia - September 7, 2021 - CAP-XX Limited (LSE:CPX), the leading manufacturer of ultra-thin prismatic and cylindrical supercapacitors, announced that Spire Health, the leading provider of respiratory remote patient monitoring (RPM), has selected the CAP-XX supercap to provide the peak power needed to deliver respiratory and pulse rate monitoring for pulmonary patients in the company's new Health Tag garment-adhered sensor. The company's original Health Tags used CAP-XX supercapacitors to deliver wellness alerts to consumers. The new Health Tag's core focus is now healthcare, where the CAP-XX supercapacitors are used to notify a patient's care team of changes in their health in an effort to enable early interventions and prevent hospital admissions.

 

Offloading the peak power role to the thin, flat supercapacitor allows Spire to keep the battery small to achieve the ultra-thin form factor of its wearable biosensor. The tag's 3V coin cell battery continuously trickle charges the CAP-XX HA114T supercapacitor (0.7mm thin, 120 millifarads, 130 milli-Ohms), which then provides the pulses of 660mW to power LED pulse rate notifications.

 

Spire Health Tags adhere to a patient's existing clothing, can be washed and dried as normal, need no charging and last up to 12 months. The Health Tags use advanced algorithms and proprietary respiratory sensors to continuously measure, with medical grade accuracy, a patient's respiratory effort, pulse rate and activity. This data is displayed on the patient's mobile app. Deviations from clinical baselines are automatically detected and shared with the patient's care team through the healthcare professional dashboard. Changes in patient health are often detected many days before a patient reports symptoms or experiences physiological decline.

 

The CAP-XX HA114T supercapacitor's features include:

· 120 mF / 2.75 Volt

· 20 x 20 x 0.7 mm

· Very low Equivalent Series Resistance (ESR) of 130 mΩ

· Up to 10 year life

 

"Spire Health Tags are the only commercial solution for remote long term, continuous monitoring of respiratory effort," said Phil Golz, Vice President, Spire Health. "The 100% passive sensor requires no interaction or engagement from patients, and research has shown that our algorithms can detect subtle changes in respiratory patterns days before patients are hospitalized due to acute exacerbations. This is tremendously exciting for the future of care for patients living with chronic respiratory conditions."

 

"CAP-XX's thin, prismatic supercaps address the size, weight and cost challenges of designing thin, sometimes disposable electronic IoT devices like wearables and portables," said Alex Bilyk, VP, Research and Development at CAP-XX. "They help IoT device manufacturers add peak-power features, extend battery life, avoid oversized batteries, or even replace batteries when paired with an energy harvester."

 

 

For further information contact:

CAP-XX Limited

Anthony Kongats (CEO)

 

+61 (0) 2 9428 0139

Kreab (Financial PR)

Robert Speed

 

+44 (0) 20 7074 1800

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Alex Brearley (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

 

+44 (0) 20 3328 5656

Cenkos Securities plc (Joint Broker)

Neil McDonald / Pete Lynch

 

+44 (0) 13 1220 6939

 

About CAP-XX

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of ultra-thin prismatic and compact cylindrical supercapacitors. Its prismatic supercapacitors are manufactured in Australia and Malaysia and its cylindrical supercapacitors are manufactured in China. The company's strong intellectual property (IP) portfolio includes 21 patents worldwide. CAP-XX's ultra-thin prismatic supercapacitors are ideal for space-constrained electronics applications where small energy storage device size and thickness are important. The unique feature of CAP-XX supercapacitors is their very high-power density and high-energy storage capacity in space-efficient thin prismatic and compact cylindrical packages. For more information about CAP-XX, visit https://www.cap-xx.com/ or email sales@cap-xx.com.

 

About Spire Health

Spire Health is the leading digital healthcare company for continuous respiratory monitoring and actionable feedback. The Spire Health Tag enables remote patient monitoring with unparalleled adherence and clinical-grade accuracy. Spire Health's remote patient monitoring approach has the potential to identify and predict health events, enable early interventions, and prevent hospital admissions. Spire is backed by leading medical health investors and has received a grant from the US Department of Health and Human Services. For more information visit: www.spirehealth.com.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGGLMVDGMZM
Date   Source Headline
4th May 20222:00 pmRNSPrice Monitoring Extension
4th May 20227:00 amRNSCAP-XX secures joint venture with Ionic Industries
12th Apr 20227:00 amRNSAppointment of Director and Grant of Share Options
28th Feb 20227:00 amRNSNotice of Investor Presentation
23rd Feb 20227:00 amRNSInterim Results
23rd Feb 20227:00 amRNSCAP-XX Secures Continental Automotive as Customer
8th Feb 20227:01 amRNSMCCI contract win
8th Feb 20227:00 amRNSCenkos Growth & Innovation Forum presentation
7th Feb 20229:00 amRNSNotification of date of interim results
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSXtel Wireless Selects CAP-XX Supercapacitors
10th Dec 20217:00 amRNSFiiO Selects CAP-XX Supercaps
6th Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSIssue of Shares and Director/PDMR Shareholdings
3rd Nov 20217:00 amRNSR&D Tax Rebate
27th Oct 20219:35 amRNSResult of AGM and Chairman’s AGM statement
14th Oct 20219:56 amRNSGrant of Share Options
5th Oct 20217:00 amRNSNotice of AGM
29th Sep 20217:00 amRNSAudited results for the year ended 30 June 2021
28th Sep 20217:00 amRNSCAP-XX Appoints Kessler Batteries as Distributor
14th Sep 20217:00 amRNSNotice of Results
7th Sep 20217:00 amRNSSpire Health Selects CAP-XX Supercapacitors
31st Aug 20215:00 pmRNSTotal Voting Rights
12th Aug 20217:00 amRNSHolding(s) in Company
11th Aug 20217:00 amRNSHolding(s) in Company
4th Aug 20217:00 amRNSResult of Placing and Completed Sale of Shares
3rd Aug 20213:33 pmRNSProposed Placing and Proposed Sale of Sale Shares
21st Jul 20217:00 amRNSRGM SpA Selects CAP-XX 3000F Supercapacitors
30th Jun 20215:00 pmRNSTotal Voting Rights
16th Jun 20217:00 amRNSSensys Networks Selects CAP-XX Supercapacitors
10th Jun 20217:00 amRNSPre-close trading update
1st Jun 20217:00 amRNSEveractive Selects CAP-XX for IoT Systems
17th May 202110:12 amRNSNotification of transactions by PDMRs
4th May 20217:00 amRNSCAP-XX Supercapacitors Selected by Jack
30th Apr 20211:03 pmRNSNotification of transactions by PDMRs
26th Apr 20217:00 amRNSVAIMOO Selects CAP-XX Supercapacitors
23rd Apr 202110:21 amRNSAppointment of Joint Broker
30th Mar 20217:00 amRNSNotification of transactions by PDMRs
23rd Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
15th Mar 20217:00 amRNSPortal Instruments Selects CAP-XX Supercapacitors
25th Feb 20217:00 amRNSInterim Results
16th Feb 202112:55 pmRNSLight energy harvesting evaluation modules
9th Feb 20217:00 amRNSTrading update and notification of date of results
5th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:15 amRNSUpdate re Tax Rebate
31st Dec 202011:31 amRNSHolding(s) in Company
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.